Skip to main content
. 2020 Jan 21;3(1):37–40. doi: 10.1016/j.jimed.2020.01.005

Table 3.

Summary of thrombosis outcomes and complications.

Group A Group B P value
Thrombus score prethrombolytic treatment 9 (8, 10) 8.3 (7, 10) 0.1922
Thrombus score post-thrombolytic treatment 3.5 (2, 5) 0 (0, 1) <0.0001
Percentage of thrombus resolution (%) 55.0 (42.3, 72.4) 94.5 (88.5, 100) <0.0001
Duration of CDT (days) 10 (9, 12) 6 (5, 7) <0.0001
Total dosage of urokinase used per patient (units) 5.950 (5.525, 7.225) ​× ​106 U 4.100 (3.600, 5.050) ​× ​106 U <0.0001
Bleeding complications (% of patients)

  • Major bleeding (incidence)

  • Minor bleeding (incidence)

 38.0% (19/50)
1
18		 22.3% (10/44)
0
10		 0.1097
–
–
Incidence of pulmonary embolism 0 0 –